Skip to main content Skip to navigation
LAMBDA-FITC / KAPPA-PE

BD Cytognos™ LAMBDA-FITC / KAPPA-PE

Clone PolyLambda+Kappa

(IVD)
Product Details
Down Arrow Up Arrow


BD Cytognos™
Human
Goat BALB/c IgG2a, Mixed
Human B-cells (except pre-B progenitors, pre-B cells)
10 µl/test
Aqueous buffered solution containing BSA and ≤0.09% sodium azide.
IVD


cyt-lf-kpe-100 Rev. 1
Antibody Details
Down Arrow Up Arrow
PolyLambda+Kappa

Human lymphocytes may be classified in three main populations according to their biological function and their cell surface antigen expression: T lymphocytes, B lymphocytes and Natural Killer cells (NK). Most B cells, with the exception of pre-B progenitors, pre-B cells, and mature plasma cells, express immunoglobulin on their surface. Each cell expresses only one Light Chain type. In normal peripheral blood and lymph nodes, there is a mixture of Kappa positive and Lambda positive cells, with two-thirds of the cells expressing Kappa and one-third expressing Lambda. Since lymphoid neoplasms are usually clonal expansions of a single cell, malignant cells uniformly express the same Light Chain isotype. Neoplastic B cell lymphoprolipherative disorders can frequently be suspected on the basis of the demonstration of a marker predominance of cells expressing a single Light Chain type.

cyt-lf-kpe-100 Rev. 1
Citations & References
Down Arrow Up Arrow
View product citations for antibody "cyt-lf-kpe-100" on CiteAb
No Citations Found

No Citations are available for this Product

cyt-lf-kpe-100 Rev. 1

Please refer to Support Documents for Quality Certificates


Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described


Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims.  Comparisons are not made against non-BD technologies, unless otherwise noted.

For In Vitro Diagnostics Use.

Documents are subject to revision without notice. Please verify you have the correct revision of the document, and always refer back to BD's eIFU website for the latest and most up to date information.